BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3023534)

  • 1. Establishment of herpes simplex virus latency in vitro with cycloheximide.
    Shiraki K; Rapp F
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2497-500. PubMed ID: 3023534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human cytomegalovirus function inhibits replication of herpes simplex virus.
    Cockley KD; Shiraki K; Rapp F
    J Virol; 1988 Jan; 62(1):188-95. PubMed ID: 2824846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein analysis of herpes simplex virus latency in vitro established with cycloheximide.
    Shiraki K; Rapp F
    Virology; 1989 Sep; 172(1):346-9. PubMed ID: 2549718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional activity of the herpes simplex virus genome during establishment, maintenance, and reactivation of in vitro virus latency.
    Scheck AC; Wigdahl B; Rapp F
    Intervirology; 1989; 30(3):121-36. PubMed ID: 2473963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of latent herpes simplex virus type 2 infection in vitro requires a (E)-5-(2-bromovinyl)-2'-deoxyuridine-sensitive gene function.
    Scheck AC; Wigdahl B; Rapp F
    Intervirology; 1987; 27(3):121-9. PubMed ID: 2822602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latency in vitro using irradiated herpes simplex virus.
    Nishiyama Y; Rapp F
    J Gen Virol; 1981 Jan; 52(Pt 1):113-9. PubMed ID: 6267167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular DNA synthesis associated with activation of latent herpes simplex virus in cell culture.
    Vonka V; Shiraki K; Wrzos J; Rapp F
    Intervirology; 1986; 25(3):144-50. PubMed ID: 3015830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of an early human cytomegalovirus function in reactivation of quiescent herpes simplex virus type 2.
    Colberg-Poley AM; Isom HC; Rapp F
    J Virol; 1981 Mar; 37(3):1051-9. PubMed ID: 6262523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hexamethylene bisacetamide and cyclosporin A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell line.
    Kondo Y; Yura Y; Iga H; Yanagawa T; Yoshida H; Furumoto N; Sato M
    Cancer Res; 1990 Dec; 50(24):7852-7. PubMed ID: 2174735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and biological characterization of an in vitro human cytomegalovirus latency model.
    Tanaka J; Ogura T; Sato H; Hatano M
    Virology; 1987 Nov; 161(1):62-72. PubMed ID: 2823470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of herpes simplex virus (HSV) type 1 genome by temperature-sensitive mutants of HSV type 2.
    Wigdahl BL; Isom HC; De Clercq E; Rapp F
    Virology; 1982 Jan; 116(2):468-79. PubMed ID: 6278723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro latency system for herpes simplex virus type 2.
    Russell J; Preston CM
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():397-403. PubMed ID: 3003243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of latency in vitro by the herpes simplex virus type 1 mutant in1814.
    Harris RA; Preston CM
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():907-13. PubMed ID: 1849973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of long-term human cytomegalovirus latency in vitro.
    Cockley KD; Rapp F
    Intervirology; 1986; 26(3):129-39. PubMed ID: 3034821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression and activation of the genome of herpes simplex viruses in human cells.
    Wigdahl BL; Isom HC; Rapp F
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6522-6. PubMed ID: 6273875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of herpes simplex virus type 1 reactivation from latency by (+-)-9-([(Z)-2-(hydroxymethyl)cyclohexyl]methyl) guanine (L-653,180) in vitro.
    Nsiah YA; Tolman RL; Karkas JD; Rapp F
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1551-5. PubMed ID: 2171423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of viral proteins in human cytomegalovirus-infected cells during impaired lytic replication of herpes simplex virus.
    Cockley KD; Rapp F
    Virology; 1989 May; 170(1):268-72. PubMed ID: 2541541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High efficiency latency and activation of herpes simplex virus in human cells.
    Wigdahl BL; Scheck AC; De Clercq E; Rapp F
    Science; 1982 Sep; 217(4565):1145-6. PubMed ID: 6180477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus latency and reactivation in isolated rat sensory neurons.
    Wigdahl BL; Ziegler RJ; Sneve M; Rapp F
    Virology; 1983 May; 127(1):159-67. PubMed ID: 6305013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of a cell model system of herpes simplex virus type II latent infection and reactivation in SH-SY5Y cells].
    Sun Z; Yang H; Shi Y; Wei M; Xian J; Hu W
    Wei Sheng Wu Xue Bao; 2010 Jan; 50(1):98-106. PubMed ID: 20344947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.